Tandem Diabetes Care Inc reports results for the quarter ended December 31 - Earnings Summary

• Tandem Diabetes Care Inc TNDM.OQ reported quarterly adjusted earnings of 1 cent​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -27 cents. The mean expectation of twenty one analysts for the quarter was for a loss of 23 cents per share. Wall Street expected results to range from -37 cents to -4 cents per share.

• Revenue rose 43.6% to $282.65 million from a year ago; analysts expected $251.98 million.

• Tandem Diabetes Care Inc's reported EPS for the quarter was 1 cent​.

• The company reported quarterly net income of $755 thousand.

• Tandem Diabetes Care Inc shares had fallen by 7.4% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 0.9% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy," 6 "hold" and 1 "sell" or "strong sell."

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for Tandem Diabetes Care Inc is $56.50

This summary was machine generated from LSEG data February 26 at 11:16 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)